These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 89330)

  • 1. Intranasal gonadotropin-releasing hormone agonist as a contraceptive agent.
    Bergquist C; Nillius SJ; Wide L
    Lancet; 1979 Aug; 2(8136):215-7. PubMed ID: 89330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
    Nillius SJ; Bergquist C; Wide L
    Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
    Nillius SJ; Bergquist C; Wide L
    Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic effects of the stimulatory luteinizing hormone-releasing hormone analogue D-Ser (TBU) 6-EA 10-LRH on the gonadotrophin and gonadal steroid secretion in women with amenorrhoea.
    Skarin G; Nillius SJ; Wide L
    Ups J Med Sci; 1980; 85(2):103-12. PubMed ID: 6787767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue - a new approach to birth control?
    Nillius SJ; Bergquist C; Wide L
    Contraception; 1978 Jun; 17(6):537-44. PubMed ID: 363344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.
    Bergquist C; Nillius SJ; Wide L; Lindgren A
    Fertil Steril; 1981 Sep; 36(3):339-42. PubMed ID: 6793403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonist.
    Bergquist C; Nillius SJ; Wide L
    Contraception; 1979 May; 19(5):497-506. PubMed ID: 380892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal LHRH agonist treatment for inhibition of ovulation in women: clinical aspects.
    Bergquist C; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1982 Jul; 17(1):91-8. PubMed ID: 6811167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term intranasal luteinizing hormone-releasing hormone agonist treatment for contraception in women.
    Bergquist C; Nillius SJ; Wide L
    Fertil Steril; 1982 Aug; 38(2):190-3. PubMed ID: 6809500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a luteinizing hormone-releasing hormone agonist on luteal function in women.
    Bergquist C; Nillius SJ; Wide L
    Contraception; 1980 Sep; 22(3):287-93. PubMed ID: 7002443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early follicular phase luteinizing hormone-releasing hormone agonist administration - effects on follicular maturation and corpus luteum function in women.
    Skarin G; Nillius SJ; Wide L
    Contraception; 1982 Jan; 25(1):31-9. PubMed ID: 6800690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of positive feedback of oestradiol during chronic intranasal luteinizing hormone-releasing hormone agonist treatment.
    Bergquist C; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1982 Feb; 16(2):147-51. PubMed ID: 6802530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin releasing hormone analogs for female contraception by inhibition of ovulation.
    Nillius SJ
    J Steroid Biochem; 1985 Nov; 23(5B):849-54. PubMed ID: 2934581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal peptide contraception by inhibition of ovulation with the gonadotropin-releasing hormone superagonist nafarelin: six months' clinical results.
    Gudmundsson JA; Nillius SJ; Bergquist C
    Fertil Steril; 1986 May; 45(5):617-23. PubMed ID: 2938984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control?
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; von der Ohe M; Nevinny-Stickel J
    Contraception; 1981 Feb; 23(2):187-95. PubMed ID: 6786826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced gonadotropin secretion in postmenopausal women during treatment with a stimulatory LRH analogue.
    Bergquist C; Nillius SJ; Wide L
    J Clin Endocrinol Metab; 1979 Sep; 49(3):472-4. PubMed ID: 381324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A; Faure N
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ovulation by intranasal nafarelin, a new superactive agonist of GnRH.
    Gudmundsson JA; Nillius SJ; Bergquist C
    Contraception; 1984 Aug; 30(2):107-14. PubMed ID: 6238805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prolonged luteinizing hormone-releasing hormone therapy on follicular maturation, ovulation and corpus luteum function in amenorrhoeic women with anorexia nervosa.
    Nillius SJ; Wide L
    Ups J Med Sci; 1979; 84(1):21-35. PubMed ID: 375526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.